Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1997 May;225(5):472–483. doi: 10.1097/00000658-199705000-00004

Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.

J A Goss 1, C R Shackleton 1, D G Farmer 1, W S Arnaout 1, P Seu 1, J S Markowitz 1, P Martin 1, R J Stribling 1, L I Goldstein 1, R W Busuttil 1
PMCID: PMC1190779  PMID: 9193175

Abstract

OBJECTIVE: The purpose of this study was to analyze a single center's 12-year experience with 127 orthotopic liver transplantations (OLT) for primary sclerosing cholangitis (PSC). SUMMARY BACKGROUND DATA: Primary sclerosing cholangitis is a chronic cholestatic liver disease of unknown origin that occurs most commonly in young men and is associated frequently (70-80%) with inflammatory bowel disease (IBD). Patients with PSC also are at risk for the development of cholangiocarcinoma (CCA) and those with IBD for colon carcinoma. Although the course of PSC is variable, it frequently is progressive, leading to cirrhosis and requirement for OLT. METHODS: The medical records of 127 consecutive patients undergoing OLT for PSC from July 1, 1984, to May 30, 1996, were reviewed. Actuarial patient and graft survival was determined at 1,2, and 5 years. The incidence and outcome of patients with CCA, recurrent sclerosing cholangitis, and post-transplant colon carcinoma was determined. Results were analyzed by way of stepwise Cox regression to determine the statistical strength of independent associations between pretransplant covariates and patient survival. The median follow-up period was 3.01 years. Incidental cholangiocarcinoma (ICCA) was defined as a tumor < 1 cm in size that was discovered at the time of pathologic sectioning of the explanted liver. RESULTS: Ninety-two patients (72%) had associated IBD. Seventy-nine (62%) had undergone previous biliary tract surgery. One hundred seven patients (84%) received a single graft, whereas 20 patients (16%) required 22 retransplants. Patients received either cyclosporine- (n = 76) or tacrolimus- (n = 51) based immunosuppression. The 1-, 2-, and 5-year actuarial patient survivals were 90%, 86%, and 85%, respectively, whereas graft survival was 82%, 77%, and 72%, respectively. The presence of previous biliary surgery had no effect on patient survival. Ten patients (8%) had ICCA and their survival was not significantly different from patients without ICCA (100%, 83%, and 83% at 1, 2, and 5 years, respectively). Four patients were known to have CCA at the time of OLT, all recurred within 6 months, and had a significantly worse outcome (p < 0.0001). Recurrent sclerosing cholangitis developed in 11 patients (8.6%). The patient and graft survival in this group was not different from those in whom recurrence did not develop (patient; 100%, 90%, and 90%; graft: 80%, 70%, and 52%). Thirty patients (23%) underwent colectomy after liver transplantation for dysplasia-carcinoma or symptomatic colitis. Of the nine covariates entered into the Cox multivariate regression analysis, only common bile duct frozen section biopsy specimen showing CCA was predictive of a survival disadvantage. CONCLUSIONS: Liver transplantation provides excellent patient and graft survival rates for patients affected with PSC independent of pretransplant biliary tract surgery. Incidental cholangiocarcinoma does not affect patient survival significantly. However, known CCA or common duct frozen section biopsy specimen or both showing CCA are associated with poor recipient survival, and OLT should be proscribed in these cases. Recurrent PSC occurs in approximately 9% of cases but does not affect patient survival. Post-transplant colectomy does not affect patient survival adversely.

Full text

PDF
472

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aadland E., Schrumpf E., Fausa O., Elgjo K., Heilo A., Aakhus T., Gjone E. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol. 1987 Aug;22(6):655–664. doi: 10.3109/00365528709011139. [DOI] [PubMed] [Google Scholar]
  2. Abu-Elmagd K. M., Malinchoc M., Dickson E. R., Fung J. J., Murtaugh P. A., Langworthy A. L., Demetris A. J., Krom R. A., Van Thiel D. H., Starzl T. E. Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet. 1993 Oct;177(4):335–344. [PMC free article] [PubMed] [Google Scholar]
  3. Abu-Elmagd K. M., Selby R., Iwatsuki S., Fung J., Tzakis A., Todo S., Demetris A. J., Baddour N., Irish W., Van Thiel D. H. Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. Transplant Proc. 1993 Feb;25(1 Pt 2):1124–1125. [PMC free article] [PubMed] [Google Scholar]
  4. Belle S. H., Detre K. M. Report from the Pitt-UNOS Liver Transplant Registry. Transplant Proc. 1993 Feb;25(1 Pt 2):1137–1142. [PubMed] [Google Scholar]
  5. Belzer F. O., D'Alessandro A. M., Hoffmann R. M., Knechtle S. J., Reed A., Pirsch J. D., Kalayoglu M., Sollinger H. W. The use of UW solution in clinical transplantation. A 4-year experience. Ann Surg. 1992 Jun;215(6):579–585. doi: 10.1097/00000658-199206000-00004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Busuttil R. W., Colonna J. O., 2nd, Hiatt J. R., Brems J. J., el Khoury G., Goldstein L. I., Quinones-Baldrich W. J., Abdul-Rasool I. H., Ramming K. P. The first 100 liver transplants at UCLA. Ann Surg. 1987 Oct;206(4):387–402. doi: 10.1097/00000658-198710000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cameron J. L., Gayler B. W., Herlong H. F., Maddrey W. C. Sclerosing cholangitis: biliary reconstruction with Silastic transhepatic stents. Surgery. 1983 Aug;94(2):324–330. [PubMed] [Google Scholar]
  8. Cameron J. L., Pitt H. A., Zinner M. J., Herlong H. F., Kaufman S. L., Boitnott J. K., Coleman J. Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis. Ann Surg. 1988 May;207(5):614–622. doi: 10.1097/00000658-198805000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chapman R. W., Arborgh B. A., Rhodes J. M., Summerfield J. A., Dick R., Scheuer P. J., Sherlock S. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut. 1980 Oct;21(10):870–877. doi: 10.1136/gut.21.10.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Collins R. H., Jr, Feldman M., Fordtran J. S. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med. 1987 Jun 25;316(26):1654–1658. doi: 10.1056/NEJM198706253162609. [DOI] [PubMed] [Google Scholar]
  11. Farges O., Malassagne B., Sebagh M., Bismuth H. Primary sclerosing cholangitis: liver transplantation or biliary surgery. Surgery. 1995 Feb;117(2):146–155. doi: 10.1016/s0039-6060(05)80078-9. [DOI] [PubMed] [Google Scholar]
  12. Farrant J. M., Hayllar K. M., Wilkinson M. L., Karani J., Portmann B. C., Westaby D., Williams R. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 1991 Jun;100(6):1710–1717. doi: 10.1016/0016-5085(91)90673-9. [DOI] [PubMed] [Google Scholar]
  13. Gordon R. D., Shaw B. W., Jr, Iwatsuki S., Esquivel C. O., Starzl T. E. Indications for liver transplantation in the cyclosporine era. Surg Clin North Am. 1986 Jun;66(3):541–556. doi: 10.1016/s0039-6109(16)43939-3. [DOI] [PubMed] [Google Scholar]
  14. Gross J. B., Jr, Ludwig J., Wiesner R. H., McCall J. T., LaRusso N. F. Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. Gastroenterology. 1985 Aug;89(2):272–278. doi: 10.1016/0016-5085(85)90326-9. [DOI] [PubMed] [Google Scholar]
  15. Higashi H., Yanaga K., Marsh J. W., Tzakis A., Kakizoe S., Starzl T. E. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology. 1990 Mar;11(3):477–480. doi: 10.1002/hep.1840110320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Ismail T., Angrisani L., Powell J. E., Hübscher S., Buckels J., Neuberger J., Elias E., McMaster P. Primary sclerosing cholangitis: surgical options, prognostic variables and outcome. Br J Surg. 1991 May;78(5):564–567. doi: 10.1002/bjs.1800780515. [DOI] [PubMed] [Google Scholar]
  17. LaRusso N. F., Wiesner R. H., Ludwig J., MacCarty R. L. Current concepts. Primary sclerosing cholangitis. N Engl J Med. 1984 Apr 5;310(14):899–903. doi: 10.1056/NEJM198404053101407. [DOI] [PubMed] [Google Scholar]
  18. Lindor K. D., Wiesner R. H., MacCarty R. L., Ludwig J., LaRusso N. F. Advances in primary sclerosing cholangitis. Am J Med. 1990 Jul;89(1):73–80. doi: 10.1016/0002-9343(90)90101-i. [DOI] [PubMed] [Google Scholar]
  19. Ludwig J., MacCarty R. L., LaRusso N. F., Krom R. A., Wiesner R. H. Intrahepatic cholangiectases and large-duct obliteration in primary sclerosing cholangitis. Hepatology. 1986 Jul-Aug;6(4):560–568. doi: 10.1002/hep.1840060403. [DOI] [PubMed] [Google Scholar]
  20. MacCarty R. L., LaRusso N. F., Wiesner R. H., Ludwig J. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology. 1983 Oct;149(1):39–44. doi: 10.1148/radiology.149.1.6412283. [DOI] [PubMed] [Google Scholar]
  21. Marsh J. W., Jr, Iwatsuki S., Makowka L., Esquivel C. O., Gordon R. D., Todo S., Tzakis A., Miller C., Van Thiel D., Starzl T. E. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg. 1988 Jan;207(1):21–25. doi: 10.1097/00000658-198801000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. McEntee G., Wiesner R. H., Rosen C., Cooper J., Wahlstrom E. A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. Transplant Proc. 1991 Feb;23(1 Pt 2):1563–1564. [PubMed] [Google Scholar]
  23. Miros M., Kerlin P., Walker N., Harper J., Lynch S., Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut. 1991 Nov;32(11):1369–1373. doi: 10.1136/gut.32.11.1369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Narumi S., Roberts J. P., Emond J. C., Lake J., Ascher N. L. Liver transplantation for sclerosing cholangitis. Hepatology. 1995 Aug;22(2):451–457. [PubMed] [Google Scholar]
  25. Nashan B., Schlitt H. J., Tusch G., Oldhafer K. J., Ringe B., Wagner S., Pichlmayr R. Biliary malignancies in primary sclerosing cholangitis: timing for liver transplantation. Hepatology. 1996 May;23(5):1105–1111. doi: 10.1002/hep.510230526. [DOI] [PubMed] [Google Scholar]
  26. Penn I. Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet. 1986 Jun;162(6):603–610. [PubMed] [Google Scholar]
  27. Quinones-Baldrich W. J., Memsic L., Ramming K., Hiatt J., Busuttil R. W. Branch patch for arterialization of hepatic grafts. Surg Gynecol Obstet. 1986 May;162(5):488–490. [PubMed] [Google Scholar]
  28. Sebagh M., Farges O., Kalil A., Samuel D., Bismuth H., Reynes M. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol. 1995 Jan;19(1):81–90. doi: 10.1097/00000478-199501000-00010. [DOI] [PubMed] [Google Scholar]
  29. Shaked A., Colonna J. O., Goldstein L., Busuttil R. W. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg. 1992 Jun;215(6):598–605. doi: 10.1097/00000658-199206000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Sheng R., Zajko A. B., Campbell W. L., Abu-Elmagd K. Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. AJR Am J Roentgenol. 1993 Aug;161(2):297–300. doi: 10.2214/ajr.161.2.8333366. [DOI] [PubMed] [Google Scholar]
  31. Stieber A. C., Marino I. R., Iwatsuki S., Starzl T. E. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg. 1989 Jan-Mar;74(1):1–3. [PMC free article] [PubMed] [Google Scholar]
  32. Thompson J. S., Wood R. P., Burnett D. A., Shaw B. W., Jr, Rikkers L. F. The role of nontransplant procedures for sclerosing cholangitis. Am J Surg. 1988 Dec;156(6):506–508. doi: 10.1016/s0002-9610(88)80540-3. [DOI] [PubMed] [Google Scholar]
  33. Wiesner R. H. Current concepts in primary sclerosing cholangitis. Mayo Clin Proc. 1994 Oct;69(10):969–982. doi: 10.1016/s0025-6196(12)61822-9. [DOI] [PubMed] [Google Scholar]
  34. Wiesner R. H., LaRusso N. F. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology. 1980 Aug;79(2):200–206. [PubMed] [Google Scholar]
  35. Wiesner R. H., LaRusso N. F., Ludwig J., Dickson E. R. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 1985 Jan;88(1 Pt 1):108–114. doi: 10.1016/s0016-5085(85)80141-4. [DOI] [PubMed] [Google Scholar]
  36. Wiesner R. H., Porayko M. K., Dickson E. R., Gores G. J., LaRusso N. F., Hay J. E., Wahlstrom H. E., Krom R. A. Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology. 1992 Nov;16(5):1290–1299. [PubMed] [Google Scholar]
  37. Wiesner R. H., Porayko M. K., Hay J. E., LaRusso N. F., Steers J. L., Krom R. A., Dickson E. R. Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. Liver Transpl Surg. 1996 Sep;2(5 Suppl 1):99–108. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES